--- firm: Pickle Jar Partners team_size: 5 preferred_stages: [series_b, series_c, series_d, series_e] priority_sectors: [b2b_saas, fintech, ai_infrastructure] adjacent_sectors: [devtools, data_infra, vertical_saas, hr_tech] avoid_sectors: [consumer, crypto, biotech, hardware, climate, energy] geography_primary: [United States] geography_secondary: [Western Europe] check_size_usd_min: 10000000 check_size_usd_max: 30000000 watchlist_threshold: 7 last_reviewed: 2026-04-01 owner: managing_partner --- # Pickle Jar Partners — Investment Thesis This is the working thesis the partners use to evaluate inbound and outbound deal flow. It also drives how the morning newsletter sweep scores the unknown companies that show up in Pro Rata. This document is the source of truth for "would we be excited about this." If the agent passes on something we'd have wanted to chase — or surfaces something we'd never touch — the thesis is the bug, not the agent. Update it. Reviewed quarterly. Partner-of-record on changes. --- ## Who we are A four-partner firm plus an office manager. We run lean by design — no analyst layer, no data team, no platform team. This shapes everything: we go deep on a small portfolio rather than wide on a big one, we don't do "ten pitches a day," and we'd rather miss a deal than misallocate a partner's morning. We're investors, not operators. Post-investment we play board observer / partner-of-record, not interim CRO. --- ## What we invest in ### Stage **Series B through Series E.** We come in after product-market fit is proven, after the company has at least one full sales cycle of data, and after a credible lead is showing conviction. We don't do pre-seed or seed; the failure mode of those rounds is a learning curve we're not built for. If a Series A company is exceptional we'll occasionally write a small check, but that's not the core motion. ### Sectors (priority order) **1. B2B SaaS.** Software sold to businesses, strong unit economics, recurring revenue. Productivity, design, project management, HR-tech, vertical SaaS. We have deep pattern recognition here from Stripe, Figma, Notion, Rippling, and Airtable in the portfolio + pipeline. **2. Fintech.** Embedded payments, business banking, corporate cards, financial connectivity, B2B financial infrastructure. Stripe, Plaid, Ramp, Brex, Mercury are reference points. **3. AI infrastructure.** Picks-and-shovels for the AI buildout — data labeling, model platforms, agentic infrastructure, evaluation/observability. We are *less* interested in vertical AI applications (the AI moat is thin) and more interested in the layer underneath them. Scale AI, Anthropic, Databricks shape our view. ### Adjacent (we'll look but the bar is higher) - **Devtools.** Vercel, Linear, GitHub-style tooling. Adjacent to AI infra and B2B SaaS. - **Data infrastructure.** Lakehouse, ETL, governance. Becomes more interesting as the AI infra layer matures. - **HR-tech.** Rippling, Deel — global hiring + payroll. We have one foot in. ### Geography - **Primary: United States.** Most of our portfolio, most of our network, most of our pattern recognition. - **Secondary: Western Europe.** Especially UK, Germany, France, Netherlands. Founders with US go-to-market presence preferred. - **Acceptable:** English-speaking elsewhere (Canada, Australia, Israel, Singapore) when the founder has US presence and US customers. - **Generally outside our model:** non-English-speaking emerging markets, India-only, China. ### Check size $10M-$30M typical. Lead or co-lead in Series B/C; follow-on in D/E. We're rarely the smallest check on the cap table — we want enough ownership to justify the partner attention. --- ## What we pass on This list matters as much as the affirmative thesis. We pass on more than we chase, and being explicit keeps us honest. - **Pre-seed and seed.** Not a learning organization at that stage. - **Pure consumer.** D2C, social, gaming, dating, creator-economy. Unit economics rarely fit our model and we don't have consumer pattern recognition. - **Pure crypto or DeFi.** We track the space (Coinbase has shown up adjacent to fintech for years) but we don't lead in it. - **Biotech, healthcare services, medical devices.** Wrong domain expertise. We refer these to friendly funds. - **Capital-intensive hardware.** Robotics, satellites, drones, semis. Anduril is in our network because we like the team and the thesis, but we're not built to lead a hardware round. - **Climate and energy.** Time horizons don't match our LPs. - **Heavy services businesses.** Staffing, BPO, consulting. We invest in software, not labor arbitrage. When in doubt, the test is: *would we be excited if a friendly fund forwarded us this deal at the round we typically lead?* If the answer requires reaching for a "well, maybe..." it's a pass. --- ## How we score new opportunities The Newsletter Sweep agent uses this rubric to surface unknown companies in the morning brief. Watchlist threshold is **7/10**. Each component is scored independently; the four scores sum and clamp to 1-10. ### Stage fit (0-3) | Score | Signal | |---|---| | 3 | Series B / C / D / E, or growth-stage strategic round, or named-investor-led growth equity | | 1 | Seed / Series A — we'll watch but not lead | | 0 | M&A target, IPO/post-IPO, undisclosed-stage rumor, or pre-seed | ### Sector fit (0-3) | Score | Signal | |---|---| | 3 | B2B SaaS / fintech / AI infrastructure (our priority list) | | 1 | Adjacent — devtools, data infra, vertical SaaS, HR-tech | | 0 | Outside — consumer, crypto, biotech, hardware, climate, energy, services | ### Geography (0-2) | Score | Signal | |---|---| | 2 | US or Western Europe HQ | | 1 | English-speaking elsewhere (CA, AU, IL, SG) with US presence | | 0 | Other | ### Signal quality (0-2) | Score | Signal | |---|---| | 2 | Traction signals — disclosed revenue, growth %, named lead, profitable, strong follow-on syndicate | | 1 | Neutral — round disclosed but no traction detail; or party round with many small checks | | 0 | Negative — lawsuit, layoffs, executive departure, down-round, distressed M&A | The components are intentionally structured so that *any* of these going to zero pulls the company below threshold. A great team in the wrong sector, or a perfect fit at the wrong stage, is still a pass. --- ## What we look for in named investors Co-investors are signal. We weight: - **Strong stage-match leads.** Sequoia / Benchmark / Founders Fund / Index / Accel leading B/C/D/E rounds are positive signal. - **Strategic-tied participation** (Stripe, Salesforce, Microsoft, Google as round participants) is a positive signal — they have unfair information. - **Crossover funds at the right stage** (Tiger, Coatue) — neutral. They participate broadly. - **Heavy party rounds** (10+ investors, no clear lead) — slight negative. This isn't part of the score directly but factors into the *signal_quality* component. --- ## How we engage post-investment - Board observer or seat where the cap table allows. - Quarterly partner cadence with the CEO; partner-of-record stays consistent. - Specific value-add: customer introductions, executive hires, market intelligence, secondary liquidity sourcing. - We don't try to be operators. If a portfolio CEO needs an interim CRO, we'll help find one — we're not it. --- ## Update protocol This document is reviewed at the end of every quarter. The owner partner brings: - Deals we passed on that should have been a fit. (False negatives.) - Deals we chased that shouldn't have been. (False positives.) - Sector or stage drift in the market that the thesis hasn't caught up to. Edits go through the same partner-of-record + sign-off cadence as a new investment. The thesis is treated as load-bearing infrastructure, not a marketing document. **Last reviewed: 2026-04-01.** **Next review: 2026-07-01.**